In a recent trial and appeal, Connolly Bove successfully sustained Pfizer's basic patent and its term extension to preserve Pfizer's exclusivity over Lipitor®.
CBLH In The News
06|20|2010
X
Email Disclaimer
The Connolly Bove Lodge & Hutz LLP website is for informational purposes only. Please be advised that contacting a Connolly Bove Lodge & Hutz LLP attorney does not establish an attorney-client relationship.
I Accept
Cancel


